Abstract
The expression of dopamine D2 receptor mRNA was studied in rat brain following micro-injection of a competitive N-methyl d-aspartate (NMDA) receptor antagonist at the prefrontal cortex. Male Sprague-Dawley rats cannulated bilaterally into the medial prefrontal cortex were injected with a competitive NMDA receptor antagonist (±)-3-(2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid (CPP). The levels of mRNA for NMDA-R1 and dopamine D2 receptors were measured by reverse transcriptase-polymerase chain reaction (RT-PCR), and D2 receptor density was quantified by [3H]spiperone binding in the cortex and striatum of these animals. In the prefrontal cortex, the levels of NMDA-R1 receptor mRNA showed significant decrease in CPP-treated animals compared to control animals. However, NMDA-R1 mRNA levels in striatum remained unchanged in any of the experimental groups. The D2 receptor mRNA levels and [3H]spiroperidol binding in prefrontal cortical membranes showed no significant difference between the CPP-treated and control groups of animals. In the striatum, a significant increase in striatal dopamine D2 receptor mRNA levels was shown in animals treated with CPP. The increase in D2 mRNA level was correlated with an increase in the D2 receptor binding sites in the striatal membranes. These results suggest a possible interaction between prefrontal cortical NMDA receptors and striatal dopamine receptors.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Albin R. L., Young A. B., and Penny J. B. (1989) The functional anatomy of basal ganglia disorders. Trends Neurosci. 12, 366–375.
Amalric M. A., Ougazzal C., Baunez S. A., and Nieoullon A. (1994) Functional interactions between glutamate and dopamine in the rat striatum. Neurochem. Int. 25, 123–131.
Baunez C., Nieoullon A., and Amalric M. (1994) N-Methyl-D-aspartate receptor blockade impairs behavioural performance of rats in a reaction time task: new evidence for glutamatergic-dopaminergic interactions in the striatum. Neuroscience 44, 521–531.
Carlsson M. and Carlsson A. (1990) Interactions between glutamatergic and monoaminergic system within the basal ganglia-implications for schizophrenia and Parkinson’s disease. Trends Neurosci. 13, 272–276.
Chomczynski P. and Sacchi N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction, Anal. Biochem. 162, 156–159.
Davies J., Evans R. H., Herrling P. L., Jones A. W., Olverman H. J., Pook P., et al. (1986) CPP, a new potent and selective NMDA antagonist. Depression of central neuron responses, affinity for [3H]D-AP5 binding sites on brain membranes and anticonvulsant activity. Brain Res. 382, 169–173.
Deutsch S. I., Mastropaolo J., Schwartz B. L., Rose R. H., and Morphia J. M. A. (1989) A ‘glutamatergic hypothesis’ of schizophrenia. Clin. Neuropharmacol. 12, 1–13.
Grace A. A. (1992), The depolarization block hypothesis of neuroleptic action: implications for the etiology and treatment of schizophrenia, J. Neural Transm., Suppl. 36, 91–131.
Garcia-Munoz M., Young S. J., and Groves P. M. (1991) Terminal excitability of the corticostriatral pathway. I. Regulation by dopamine receptor stimulation. Brain Res. 551, 195–206.
Healy J. D. and Meador-Woodruff H. J. (1996) Differential regulation, by MK801, of dopamine receptor gene expression in rat nigrostriatal and mesocorticolimbic systems. Brain Res. 708, 38–44.
Kondoh T. and Low W. C. (1994) Glutamate uptake blockade induces striatal dopamine release in 6-hydroxy dopamine rats with intrastriatal grafts: evidence for host modulation of transplanted dopamine neurons. Exp. Neurol. 127, 191–198.
Kötter R. (1994) Postsynaptic integration of glutamatergic and dopaminergic signals in the striatum. Prog. Neurobiol. 44, 163–196.
Lannes B., Bernard V., Bloch B., and Micheletti G. (1995) Chronic treatment with dizocilpine maleate increases the number of striatal neurons expressing the D2 receptor gene. Neuroscience 65, 431–438.
Lesch K. P., Aulakh S. C., Wolozin L. B., Hill L. J., and Murphy L. D. (1992) 3-(2-Carboxypiperazin-4-yl)propyl-1-phosphonic acid decreases NMDA receptor mRNA. Eur. J. Pharmacol. 227, 109–111.
McGeorge A. J. and Faull R. L. M. (1989) The organization of the projection from the cerebral cortex to the striatum in the rat. Neuroscience 29, 503–537.
Micheletti G., Lannes B., Haby C., Borrelli E., Kempf E., Warter J.-M., and Zwiller J. (1992) Chronic administration of NMDA antagonists induces D2 receptor synthesis in rat striatum. Mol. Brain Res. 14, 363–368.
Monsma F. J., Jr., McVitte L. D., Gerfen C. R., Mahan L. C., and Sibly D. R. (1989) Multiple D2 dopamine receptors produced by alternative RNA splicing. Nature 342, 926–929.
Morari M., O’Connor W. T., Ungerstedt U., and Fuxe K. (1993) Dopamine D1 and D2 receptor antagonism differentially modulates stimulation of striatal neurotransmitter levels by N-methyl-D-aspartic acid. Eur. J. Pharmacol. 256, 23–30.
Savelli J. E., Chugh A., Cheng C., Mishra R. K., and Johnson R. L. (1995) Modulation of N-methyl-D-aspartate (NMDA) antagonist-induced darting behaviour by the peptidomimetic PAMTA. Brain Res. 682, 41–49.
Smith A. D. and Bolam J. P. (1990) The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurones. Trends Neurosci. 13, 259–265.
Srivastava L. K., Morency M. A., and Mishra R. K. (1992) Ontogeny of dopamine D2 receptor mRNA in rat brain. Eur. J. Pharmacol. 225, 143–150.
Starr M. S. and Starr B. S. (1994) Comparison of the effects of NMDA and AMPA antagonists on the locomotor activity induced by selective D1 and D2 dopamine agonists in reserpine treated mice. Psychopharmacology 114, 469–476.
Taber T. M. and Figiber H. C. (1993) Electrical stimulation of the medial prefrontal cortex increases dopamine release in the striatum. Neuropsychopharmacology 9, 271–275.
Tingley W. G., Roche K. W., Thompson A. K., and Huganir R. L. (1993) Regulation of NMDA receptor phosphorylation by alternative splicing of the C-terminal domain. Nature 364, 70–73.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nair, V.D., Savelli, J.E. & Mishra, R.K. Modulation of dopamine D2 receptor expression by an NMDA receptor antagonist in rat brain. J Mol Neurosci 11, 121–126 (1998). https://doi.org/10.1385/JMN:11:2:121
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/JMN:11:2:121